Moxisylyte

CHEMBL159226 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

279.4 g/mol

LogP

3.2

Phase

4

An alpha-1 adrenergic blocker used in some countries to treat Raynaud's phenomenon and erectile dysfunction by relaxing smooth muscle and improving blood flow. It works by blocking alpha-adrenergic receptors in blood vessel walls.

Peso Molecular

279,3700 g/mol

LogP

3,20

TPSA

38,80 Å²

Regra dos 5 de Lipinski

Aprovado

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C

InChI

InChI=1S/C16H25NO3/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6/h9-11H,7-8H2,1-6H3

Molecular Formula

C16H25NO3

HBD / HBA

- / 4

Ligações Rotacionáveis

7

Átomos Pesados

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

An alpha-1 adrenergic blocker used in some countries to treat Raynaud's phenomenon and erectile dysfunction by relaxing smooth muscle and improving blood flow. It works by blocking alpha-adrenergic receptors in blood vessel walls.

Yes, Moxisylyte is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL159226. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4260. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Moxisylyte no PillFYI

Estrutura

Dados Rápidos

Fórmula: C16H25NO3

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.